Cargando…

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland

Chimeric antigen receptor T (CAR-T) cells are genetically modified autologous T cells that have revolutionized the treatment of relapsing and refractory haematological malignancies. In this review we present molecular pathways involved in the activation of CAR-T cells, describe in details the struct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ślebioda, Tomasz J., Stanisławowski, Marcin, Kaszubowska, Lucyna, Zaucha, Jan M., Żmijewski, Michał A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687915/ https://www.ncbi.nlm.nih.gov/pubmed/36428480 http://dx.doi.org/10.3390/biomedicines10112912

Ejemplares similares

Current and future perspectives of chimeric antigen receptors against glioblastoma
por: Zhang, Josephine, et al.
Publicado: (2022)

Expression of cellular protective proteins SIRT1, HSP70 and SOD2 correlates with age and is significantly higher in NK cells of the oldest seniors
por: Kaszubowska, Lucyna, et al.
Publicado: (2017)

NK cells of the oldest seniors represent constant and resistant to stimulation high expression of cellular protective proteins SIRT1 and HSP70
por: Kaszubowska, Lucyna, et al.
Publicado: (2018)

Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells
por: Pierzynowska, Karolina, et al.
Publicado: (2023)

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future
por: Li, Long, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
por: Kringel, Rebecca, et al.
Publicado: (2023)

The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer
por: Choi, Ji-Young, et al.
Publicado: (2023)

Chimeric Antigen Receptor T-Cells: The Future Is Now
por: Mchayleh, Wassim, et al.
Publicado: (2019)

Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
por: Wang, Zhenguang, et al.
Publicado: (2017)

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia
por: Maucher, Marius, et al.
Publicado: (2021)

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives
por: Maher, John
Publicado: (2023)

Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma
por: KLACZ, JAKUB, et al.
Publicado: (2015)

Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma
por: Wierzbicki, Piotr M., et al.
Publicado: (2014)

Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives
por: Qu, Jingjing, et al.
Publicado: (2020)

Current Advances and Hurdles in Chimeric Antigen Receptor Technology
por: McComb, Scott, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
por: Heyman, Benjamin, et al.
Publicado: (2019)

Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: history, current situation, and future
por: Muller, Bradley J., et al.
Publicado: (2023)

Is Chimeric Antigen Receptor T-cell Therapy the Future of Autoimmunity Management?
por: Tahir, Amber
Publicado: (2018)

Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology
por: Yoo, Hyeon Joo, et al.
Publicado: (2021)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
por: Voynova, Elisaveta, et al.
Publicado: (2021)

The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children
por: Liberek, Anna, et al.
Publicado: (2012)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies
por: Xie, Bailu, et al.
Publicado: (2022)

Chimeric Antigen Receptor Regulatory T Cell in Transplantation: The Future of Cell Therapy?
por: Lamarche, Caroline, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
por: Srour, Samer A., et al.
Publicado: (2022)

Introducing of the First DCD Kidney Transplantation Program in Poland
por: Stadnik, Honorata, et al.
Publicado: (2019)

Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
por: Ou, Lijia, et al.
Publicado: (2023)

Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer
por: Ślebioda, Tomasz Jerzy, et al.
Publicado: (2019)

Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017)

Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
por: Marei, Hany E., et al.
Publicado: (2021)

The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice
por: Gatkowska, Justyna, et al.
Publicado: (2019)

Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions
por: Chavez, Julio C, et al.
Publicado: (2021)

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
por: Shi, Huan, et al.
Publicado: (2014)

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
por: Fujiwara, Yuki, et al.
Publicado: (2022)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011)

The Immunogenic and Immunoprotective Activities of Recombinant Chimeric T. gondii Proteins Containing AMA1 Antigen Fragments
por: Gatkowska, Justyna, et al.
Publicado: (2020)

Chimeric antigen receptors that trigger phagocytosis
por: Morrissey, Meghan A, et al.
Publicado: (2018)

Chimeric Antigen Receptors for T-Cell Malignancies
por: Scherer, Lauren D., et al.
Publicado: (2019)

Engineering and Design of Chimeric Antigen Receptors
por: Guedan, Sonia, et al.
Publicado: (2018)

The Chimeric Antigen Receptor Detection Toolkit
por: Hu, Yifei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hlehqer3jo9kockg58k7gfgnl7